Compare ALIT & MOBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALIT | MOBI |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 394.4M | 383.0M |
| IPO Year | 2020 | 2026 |
| Metric | ALIT | MOBI |
|---|---|---|
| Price | $14.15 | $12.04 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $3.75 | N/A |
| AVG Volume (30 Days) | ★ 478.1K | 155.8K |
| Earning Date | 05-05-2026 | N/A |
| Dividend Yield | ★ 21.33% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,262,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.14 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.48 | $10.34 |
| 52 Week High | $23.68 | $15.19 |
| Indicator | ALIT | MOBI |
|---|---|---|
| Relative Strength Index (RSI) | 48.99 | 53.24 |
| Support Level | $13.07 | $10.67 |
| Resistance Level | $15.54 | $12.26 |
| Average True Range (ATR) | 0.69 | 0.93 |
| MACD | -0.04 | 0.13 |
| Stochastic Oscillator | 51.48 | 69.50 |
Alight Inc is a technology-enabled services company delivering human capital management solutions to many complex organizations. This includes the implementation and administration of employee benefits (e.g., health, wealth, and leave benefits) solutions, which currently operate under one reportable segment, Employer Solutions. The Employer Solutions segment is driven by the Alight Worklife platform, and includes integrated benefits administration, healthcare navigation, financial well-being, leave of absence management, and retiree healthcare. Geographically, the company generates the majority of its revenue from the United States.
Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The company develops, markets and sells devices for the treatment of medical conditions. Its flagship device is the Vivistim Paired Vagus Nerve Stimulation system, which is used to support motor function rehabilitation in patients with chronic ischemic stroke. The company generates all of its revenue from the sale of the Vivistim System to customers, mainly primary and comprehensive stroke centers, in the United States.